Rchr
J-GLOBAL ID:201801012345530637   Update date: Sep. 08, 2024

Kada Akiko

Kada Akiko
Affiliation and department:
Research field  (2): Hygiene and public health (non-laboratory) ,  Statistical science
Research keywords  (2): 臨床研究のデザインと解析 ,  生物統計
Research theme for competitive and other funds  (6):
  • 2023 - 2026 Development of Statistical Analysis Methods Using Restricted Mean Survival Time in Small Clinical Trials
  • 2019 - 2023 Generalization of treatment effect using similarity of populations
  • 2018 - 2022 脳卒中のLearning Healthcare Systemに関する研究
  • 2015 - 2019 Development trial design in rare disease using registry data
  • 2013 - 2017 Evaluation of the impact of benchmark using large scale stroke cohort based on DPC database.
Show all
Papers (113):
  • Hideo Saka, Masahide Oki, Yoshikane Yamauchi, Chiyoe Kitagawa, Akiko Kada, Akiko M Saito, Haruhiko Kondo, Hirotaka Kida, Noriaki Takahashi, Akihiro Bessho, et al. Talc slurry pleurodesis in patients with secondary intractable pneumothorax: A phase 2 study. Respiratory investigation. 2024. 62. 2. 277-283
  • Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Takeshi Mori, Akiko M Saito, et al. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial. European journal of haematology. 2023
  • Yoshihito Kogure, Akiko Kada, Hiroya Hashimoto, Shinji Atagi, Yuichi Takiguchi, Hideo Saka, Noriyuki Ebi, Akira Inoue, Takayasu Kurata, Yuka Fujita, et al. Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study. JTO clinical and research reports. 2023. 4. 6. 100514-100514
  • Ryota Kurogi, Akiko Kada, Kuniaki Ogasawara, Kunihiro Nishimura, Takanari Kitazono, Toru Iwama, Yuji Matsumaru, Nobuyuki Sakai, Yoshiaki Shiokawa, Shigeru Miyachi, et al. National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study. BMJ Open. 2023. 13. 4. e068642-e068642
  • Ai Kurogi, Daisuke Onozuka, Akihito Hagihara, Kunihiro Nishimura, Akiko Kada, Manabu Hasegawa, Takahiro Higashi, Takanari Kitazono, Tsuyoshi Ohta, Nobuyuki Sakai, et al. Influence of hospital capabilities and prehospital time on outcomes of thrombectomy for stroke in Japan from 2013 to 2016. Scientific Reports. 2022. 12. 1
more...
MISC (51):
  • 小暮 啓人, 嘉田 晃子, 橋本 大哉, 安宅 信二, 滝口 裕一, 坂 英雄, 海老 規之, 井上 彰, 倉田 宝保, 藤田 結花, et al. 高齢者肺扁平上皮肺癌における2次治療のICIの検討 CAPITAL試験の事後解析. 肺癌. 2022. 62. 6. 650-650
  • 堀 大紀, 小林 良二, 中澤 温子, 岩淵 英人, Klapper Wolfram, 大隈 朋生, 藤田 直人, 三井 哲夫, 古賀 友紀, 森 健, et al. 日本の小児びまん性大細胞型B細胞リンパ腫における非胚中心B細胞型(non-GCB)の検討. 日本血液学会学術集会. 2022. 84回. 918-918
  • 森 鉄也, 大隅 朋生, 嘉田 晃子, 大木 健太郎, 古賀 友紀, 深野 玲司, 藤田 直人, 三井 哲夫, 森 健, 齋藤 明子, et al. 小児高リスク群バーキットリンパ腫に対するリツキシマブ追加化学療法 JPLSG B-NHL14試験. 日本血液学会学術集会. 2022. 84回. 917-917
  • 橋本大哉, 嘉田晃子. 小標本の制限付き平均生存時間の推定に対する打ち切りの影響. 統計関連学会連合大会講演報告集. 2022. 2022
  • 橋本大哉, 嘉田晃子. 制限付き平均生存時間に対する変数変換を用いた信頼区間推定. 日本計量生物学会年会講演予稿集. 2022. 2022
more...
Lectures and oral presentations  (1):
  • 臨床研究の計画と解析におけるピットフォール
    (第30回日本心臓リハビリテーション学会学術集会 2024)
Professional career (1):
  • Muster of Public Health (Kyoto University)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page